Thromb Haemost 2006; 95(06): 1025-1030
DOI: 10.1160/TH06-04-0190
Meeting Report
Schattauer GmbH

Endothelial cell biology: An update

5th International Symposium on the Biology of Endothelial Cells
Henning Morawietz
1   Department of Vascular Endothelium and Microcirculation, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Dresden, Germany
,
Georg Breier
2   Institute of Pathology, Medical Faculty Carl Gustav Carus, University of Technology Dresden; Dresden, Germany
› Author Affiliations
Financial support: The conference was supported by the Deutsche Forschungsgemeinschaft, the Medical Faculty Carl Gustav Carus of the University of Technology Dresden, Germany, and the German Federal Ministry of Education and Research (BMBF) program NBL3 of the University of Technology Dresden, Germany. Additional support was provided by a number of corporate sponsors (Amaxa Biosystems, Bayer Healthcare, Ibidi Integrated Biodiagnostics, Noxygen, Npi Electronic, Promega, Promocell, Reliatech, Sanofi-Aventis, Schering Oncology, Whatman Biometra).
Further Information

Publication History

Received 05 April 2006

Accepted 20 April 2006

Publication Date:
02 December 2017 (online)

Summary

The 5th International Symposium on the Biology of Endothelial Cells was held in Dresden, Germany. The meeting included sessions on endothelial cell differentiation, tumor and lymph angiogenesis, endothelial cell junctions and barrier function, biomechanical control of endothelial function, oxidative stress and endothelial dysfunction, hypoxia and VEGF-induced signaling, inflammation and angiogenesis. This report summarizes the key findings of the platform presentations of the meeting.

 
  • References

  • 1 Zeng Q, Li S, Chepeha DB. et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 2005; 08: 13-23.
  • 2 Fischer A, Klattig J, Kneitz B. et al. Hey basic helixloop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts. Mol Cell Biol 2005; 25: 8960-70.
  • 3 Foo SS, Turner CJ, Adams S. et al. Ephrin-B2 controls cell motility and adhesion during blood-vesselwall assembly. Cell 2006; 124: 161-73.
  • 4 Korff T, Dandekar G, Pfaff D. et al. Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31. Arterioscler Thromb Vasc Biol 2006; 26: 468-74.
  • 5 Lu X, Le Noble F, Yuan L. et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 2004; 432: 179-86.
  • 6 Suchting S, Heal P, Tahtis K. et al. Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration. FASEB J 2005; 19: 121-3.
  • 7 Rajendran L, Simons K. Lipid rafts and membrane dynamics. J Cell Sci 2005; 118: 1099-102.
  • 8 Hirakawa S, Kodama S, Kunstfeld R. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005; 201: 1089-99.
  • 9 Kajiya K, Hirakawa S, Ma B. et al. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005; 24: 2885-95.
  • 10 Ny A, Koch M, Schneider M. et al. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat Med 2005; 11: 998-1004.
  • 11 Brouillard P, Ghassibe M, Penington A. et al. Four common glomulin mutations cause two thirds of glomuvenous malformations (“familial glomangiomas”): evidence for a founder effect. J Med Genet 2005; 42: e13.
  • 12 Khandoga A, Kessler JS, Meissner H. et al. Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 2005; 106: 725-33.
  • 13 Baumeister U, Funke R, Ebnet K. et al. Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J 2005; 24: 1686-95.
  • 14 Chavakis T, Wiechmann K, Preissner KT. et al. Staphylococcus aureus interactions with the endothelium: the role of bacterial “secretable expanded repertoire adhesive molecules” (SERAM) in disturbing host defense systems. Thromb Haemost 2005; 94: 278-85.
  • 15 Parmar KM, Larman HB, Dai G. et al. Integration of flow-dependent endothelial phenotypes by Kruppellike factor 2. J Clin Invest 2006; 116: 49-58.
  • 16 Li JM, Fan LM, Christie MR. et al. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005; 25: 2320-30.
  • 17 Berra E, Ginouves A, Pouyssegur J. The hypoxiainducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep 2006; 07: 41-5.
  • 18 Schanzer A, Wachs FP, Wilhelm D. et al. Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 2004; 14: 237-48.
  • 19 Matsumoto T, Bohman S, Dixelius J. et al. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J 2005; 24: 2342-53.
  • 20 Petzelbauer P, Zacharowski PA, Miyazaki Y. et al. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 2005; 11: 298-304.
  • 21 Fiedler U, Reiss Y, Scharpfenecker M. et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12: 235-9.
  • 22 Cavanagh LL, Bonasio R, Mazo IB. et al. Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nat Immunol 2005; 06: 1029-37.